J, N., J, L., A, F., S, O., S, M., J, P., . . . J, N. (2018). β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas. The Journal of clinical investigation, 128(5), 2048. https://doi.org/10.1172/JCI95351
Chicago Style (17th ed.) CitationJ, Nsengimana, et al. "β-Catenin-mediated Immune Evasion Pathway Frequently Operates in Primary Cutaneous Melanomas." The Journal of Clinical Investigation 128, no. 5 (2018): 2048. https://doi.org/10.1172/JCI95351.
MLA (9th ed.) CitationJ, Nsengimana, et al. "β-Catenin-mediated Immune Evasion Pathway Frequently Operates in Primary Cutaneous Melanomas." The Journal of Clinical Investigation, vol. 128, no. 5, 2018, p. 2048, https://doi.org/10.1172/JCI95351.
Warning: These citations may not always be 100% accurate.